Humacyte, Inc. (HUMA) earnings
HUMA earnings moved a median of +2.07% by the close. Quarterly and annual HUMA reports and results, each read against the price at its own news timestamp. Back to the HUMA overview →
21 measured HUMA earnings events.
Where these HUMA earnings landedvs 19 measured HUMA earnings reactions
| Middle 50% of HUMA earnings reactions | -12.81% to +7.70% |
|---|---|
| Median reaction (to close) | +2.07% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 HUMA earnings events with a measured close landed between -12.81% and +7.70%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Humacyte, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.17% | +2.07% | |
| Humacyte Reports Third Quarter 2026 Results, Highlighted by More Than Doubling Symvess Revenue and Expanding Commercial Adoption | Press release | +8.34% | +18.00% | |
| Form 10-Q Humacyte, Inc. For: Jun 30 | SEC filing · Form 10-Q | +4.59% | -14.20% | |
| Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update | Press release | +1.15% | +2.31% | |
| Form 10-Q Humacyte, Inc. For: Mar 31 | SEC filing · Form 10-Q | -6.96% | -13.04% | |
| Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update | Press release | +15.11% | +26.29% | |
| Form 10-K Humacyte, Inc. For: Dec 31 | SEC filing · Form 10-K | -5.71% | -16.80% | |
| Form 10-Q Humacyte, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.41% | — | |
| Humacyte Announces Third Quarter 2025 Financial Results and Provides Business Update | Press release | -5.94% | -12.59% | |
| Form 10-Q Humacyte, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.28% | — | |
| Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update | Press release | -8.86% | -14.04% | |
| Form 10-Q Humacyte, Inc. For: Mar 31 | SEC filing · Form 10-Q | +7.06% | +5.65% | |
| Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update | Press release | +2.29% | +13.07% | |
| Form 10-K Humacyte, Inc. For: Dec 31 | SEC filing · Form 10-K | -4.62% | -13.87% | |
| Form 10-Q Humacyte, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.07% | -4.83% | |
| Humacyte Third Quarter 2024 Financial Results and Business Update | Press release | +4.29% | +12.67% | |
| Form 10-Q Humacyte, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.48% | -9.62% | |
| Humacyte Second Quarter 2024 Financial Results and Business Update | Press release | +3.23% | +2.31% | |
| Form 10-Q Humacyte, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.39% | +9.74% | |
| Humacyte First Quarter 2024 Financial Results and Business Update | Press release | +0.89% | +4.44% | |
| Form 10-K Humacyte, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.32% |
Keep exploring
More HUMA: analyst actions → · SEC filings → · HUMA overview →